SCHEMBL7085876

SCHEMBL7085876

NC(=O)CCNc1nsc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 9/20 0.46
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ACHE P22303 2/20 0.41
EPHX2 P34913 1/20 0.40
SIRT5 Q9NXA8 2/20 0.39
KMT2A Q03164 1/20 0.39
BCHE P06276 1/20 0.38
CSNK2A2 P19784 2/20 0.36
CSNK2B P67870 2/20 0.36
CSNK2A1 P68400 2/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
OGFRL1 Q5TC84 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13202776 0.82 EPAS1 (0.59) EPAS1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL2977289 0.80 EPAS1 (0.53) EPAS1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL13202796 0.79 EPAS1 (0.56) EPAS1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL7975860 0.78 EPAS1 (0.54) EPAS1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL6108893 0.77 EPAS1 (0.50) EPAS1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL2974074 0.76 HTR1A (0.51) EPAS1MAPTALDH1A1KMT2A
SCHEMBL2977230 0.75 CYP2C19 (0.43) EPAS1MAPTALDH1A1HSD17B10ACHE
SCHEMBL2976797 0.74 EPAS1 (0.42) EPAS1MAPTACHE
SCHEMBL2976803 0.74 EPAS1 (0.42) EPAS1MAPTACHE
SCHEMBL2979186 0.74 KCNA3 (0.46) EPAS1MAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-B1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMA (US) 2003-07-02 EP disclosed